About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2118 blog entries.

North Carolina

The Board of Pharmacy announced it is pursuing administrative rulemaking concerning “direct-to-patient delivery systems” for pharmacies allowing for technologies where drugs are dispensed directly to patients. The Board will host a public hearing on this issue on June 13, and written comments are due by June 16.  Below is more information on this proposed rule which the North Carolina Retail Merchants Association is in the process of analyzing.   

PUBLIC HEARING AND COMMENT PERIOD — JUNE 13, 2023 — ON THE FOLLOWING PROPOSED ACTIONS: 

ADOPTION OF 21 NCAC 46 .1821 DIRECT-TO-PATIENT DELIVERY SYSTEMS 

AMENDMENT TO 21 NCAC 46 .1616 LIMITED SERVICE PERMITS 

Reason for Proposed Action: 

The Board of Pharmacy proposes to adopt a rule permitting pharmacies to employ certain direct to patient systems, which are technologies that dispense drugs directly to patients. The proposed rule contains provisions to allow pharmacies to comply with the laws governing dispensing drugs, devices, or medical equipment while using these systems. The proposed rule further contains provisions that would ensure that the systems can be used safely and securely, that required records are maintained, that the home pharmacy can adequately supervise and service these systems, and that patients may use these systems while also receiving information, safeguards and counseling that they need to use their drugs, devices, and medical equipment safely. There is an accompanying proposed change to the Board of Pharmacy’s limited-service permit rules to provide for permitting of systems that a pharmacy may place in a location other than the home pharmacy’s facility. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2023-10-10T09:01:17-04:00March 31, 2023|North Carolina|

Oklahoma

Beginning April 1, 2023, the Oklahoma Health Care Authority (OHCA) will begin disenrollment of certain individuals that have been continuously enrolled in SoonerCare (Oklahoma Medicaid program) that no longer meet eligibility requirements. For more information, see Bulletin No. 2-2023.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-31T09:33:35-04:00March 31, 2023|Oklahoma|

Oregon

The Board of Pharmacy posted the agenda and meeting materials for the next Board Meeting scheduled for April 12-14; see additional details below. Also, please note the following agenda item:  

  • Div 019/020- Pharmacist Prescriptive Authority – COVID-19 Monoclonal Antibody, COVID-19 Antiviral, Continuation of Therapy including emergency refills of insulin, Contraception, PEP, PrEP, Travel Medications Protocols- #A2, A2a, A2b, A2c, A2d, A2e. See pp 47-103 (inclusive) of the PDF. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-03-31T09:33:03-04:00March 31, 2023|Oregon|

South Dakota

On March 23, South Dakota Gov. Kristi Noem (R) signed HB 1135; PBM legislation includingrequirements for PBM licensure, prohibiting retroactive fees except in certain situations and the collection of renumeration fees, and adding criteria for drugs to be placed on the MAC list.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-03-31T09:32:13-04:00March 31, 2023|South Dakota|

Texas

Walgreens pharmacist Aimee Lusson testified at the House Public Health Committee on March 27 in support of HB 2088 by Rep. John H. Bucy III (D), on emergency insulin supply legislation. 

Also in Texas, Rep. Tom Oliverson’s HB 1543, legislation establishing a statewide standing order for prescribing an opioid antagonist, will be heard in the House Public Health Committee on April 3. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-31T09:31:23-04:00March 31, 2023|Texas|

Virginia

Gov. Glenn Youngkin (R) signed SB 1538 into law. This bill, sponsored by Senator Pillion (R), requires the Department of Medical Assistance Services to provide reimbursement when the services provided for by the state plan for medical assistance services are services by a pharmacist, pharmacy technician or pharmacy intern (i) performed under the terms of a collaborative agreement as defined in relevant law and consistent with the terms of a managed care contractor provider contract or the state plan or (ii) related to services and treatment in accordance with relevant law. NACDS supported the efforts of the Virginia Association of Chain Drug Stores and the Virginia Pharmacists Association as it moved through the process.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-03-31T09:28:26-04:00March 31, 2023|Virginia|

West Virginia

Gov. Jim Justice (R) signed the following priority bills into law on March 23: 

  • Committee Substitute SB 345, a bill that would provide legislative approval of the PBM rule pursuant to the passage of HB 4112 of 2022. Effective from passage – March 10, 2023. 
  • HB 2754 adopts the immunization authority from the federal PREP Act into state law. It allows both pharmacists and pharmacy technicians to administer all vaccines to patients aged three years and older and removes the long-standing prescription requirement for children. Effective from passage – March 7, 2023. 

NACDS thanks our members, Bridget Lambert of the West Virginia Retailers Association, Conrad Lucas of Capitol Resources and the West Virginia Pharmacists Association for their daily engagement on getting HB 2754 across the finish line.  

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-03-31T09:27:41-04:00March 31, 2023|West Virginia|

Wyoming

Stating cost shifting to consumers among his concerns and exercising his line-item veto authority, Gov. Mark Gordon (R) signed SF 151, legislation amending the Insurance Code to further regulate PBMs. The new law includes language that prohibits certain fees and claw backs, prohibits PBMs from restricting or limiting disclosure of information to the insurance commissioner for investigations or review of PBMs, requires contracts between PBMs and pharmacies to include a dispute resolution process, amends MAC and MAC appeals, permits refusal to fill below-cost prescriptions and provides for one-time resources for implementation and administration of this act. The Governor’s veto message and the bill with the Governor’s vetoes are available online.

Also in Wyoming, the Office of the Attorney General published two final rules amending the lists of Schedule I and Schedule II controlled substances in the Wyoming Controlled Substances Act of 1971, effective March 22, 2023.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-03-31T09:27:13-04:00March 31, 2023|Wyoming|

Alaska

The Board of Pharmacy issued Proposed Regulations relating to classifications of licensure, registration, application, license and registration renewal, notification process for changes in name, ownership or physical address of pharmacies, pharmacist-in-charge, pharmacist interns, job shadowing, security, remote pharmacy, return or exchange of drugs, automated distribution kiosks, remodeling, designated representative, drug recalls, facilities, prescription drug monitoring program, and definitions. Written comments deadline is 4:30 p.m. on April 24.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-24T10:10:12-04:00March 24, 2023|Alaska|
Go to Top